Self-reported OSA tied to memory deficits and higher vascular risk load in 40-70 age group
Self-reported untreated OSA was associated with poorer memory and greater vascular dementia risk burden in midlife adults; vascular factors explained only part of the link. The cross-sectional, self-report design limits causal inference. Randomized treatment trials with biomarker endpoints are required to test whether early OSA management alters cognitive trajectories.
Next steps include planned Monash-led randomized trials that will combine OSA treatment with vascular-risk optimization and track incident mild cognitive impairment over five to seven years. Such trials must report both adherence-adjusted effect sizes and changes in hippocampal volume or amyloid PET to move beyond the current observational ceiling.
Monash investigators: a 5-year RCT of CPAP plus vascular management in 40-60-year-olds with moderate-severe OSA will show at least 20% slower decline on composite memory z-score versus usual care.
Sources (3)
- [1]Primary Source(https://doi.org/10.1002/alz.71553)
- [2]Supporting Source(https://www.nejm.org/doi/10.1056/NEJMra2200575)
- [3]Supporting Source(https://jamanetwork.com/journals/jamaneurology/fullarticle/2798921)